Abbott Diagnostics Technologies AS
Score · fiscal year 2023
52of 100
How to read this: the company is ahead of 54 % of companies in the Morning class Large in the same sector in 2023. What does this mean?
Rank in the Morning class Large: 129 of 278 · What are Morning company classes?
Place in the whole sector: 1,084 of 2,341 · Industri
Profile
Elephant · Steward
Lower profitability, high solidity
Position against comparable companies in 2023, not a verdict on the company. Based on profitability 24 and solidity 96 out of 100 among companies in the Morning class Large in the same sector in 2023. Methodology
Against the sector
Abbott Diagnostics Technologies AS is 3 points above the median for companies in the Morning class Large in the same sector in 2023.
Median score 49 among 278 companies.
Against companies in the Morning class Large in the same sector in 2023: operating margin −0.5% (median 5.7%) and equity ratio 79.2% (median 33.0%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 1,380 MNOK | 1,181 MNOK |
| Operating margin | −0.5% | 5.7% |
| Profit margin | 5.7% | 5.4% |
| Return on assets | 8.0% | 12.1% |
| Equity ratio | 79.2% | 33.0% |
| Debt-to-equity | 0.26 | 2.02 |
| Current ratio | 1.47 | 1.34 |
| Revenue growth | – | 1.9% |
| Revenue per employee | 4.95 MNOK | 5.46 MNOK |
The median and “ahead of” refer to companies in the Morning class Large in the same sector in 2023. The bar shows the share of companies the figure is ahead of.
With an index of 52, Abbott Diagnostics Technologies AS does better than 54% of companies in the Morning class Large in the same sector (278 companies) in 2023.
Score 2023–2025
- Abbott Diagnostics Technologies AS
- Median: companies in the Morning class Large in the same sector
What the numbers say
Abbott Diagnostics Technologies AS had an operating margin of −0.5% and an equity ratio of 79.2% in 2023, and ranks 1,084 of 2,341 in Industri.
This text is generated automatically from the 2023 accounts.
Three simple methods
The methods give between 623 MNOK and 1,265 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 623 MNOK |
| EV/EBIT | 8.0 | not meaningful |
| P/B | 1.0 | 1,265 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
The operating margin is lower than at three in four companies in the sector. Where do costs differ from competitors?
Based on: Operating margin −0.5% (median 5.7%).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 14.6% of the debt in 2023. The policy rate averaged 3.54 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of −0.8%. Based on the 10 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 24 | weight 30% |
|---|---|---|
| Solidity | 96 | weight 25% |
| Liquidity | 62 | weight 15% |
| Growth | – | no data, left out |
| Consistency | 23 | weight 15% |
Index version 2. Data completeness 85%: the share of the weights that had data.
Questions and answers
How profitable is Abbott Diagnostics Technologies AS?
The operating margin was −0.5% in 2023, against a median of 5.7% among companies in the Morning class Large in the same sector. Return on assets was 8.0%.
How solid is Abbott Diagnostics Technologies AS?
The equity ratio was 79.2% in 2023 (median 33.0%). Debt-to-equity was 0.26 (median 2.02).
What is the liquidity of Abbott Diagnostics Technologies AS like?
The current ratio was 1.47 in 2023 (median 1.34).
How does Abbott Diagnostics Technologies AS compare in Industri?
Abbott Diagnostics Technologies AS ranks 1,084 of 2,341 in Industri for 2023. Among companies in the Morning class Large it is number 129 of 278.
From the Central Coordinating Register
- Org. no.
- 981363019
- Legal form
- AS
- Sector
- Industri (21.200)
- Morning company class
- Large
- Employees
- 279 registered 10 October 2026
- Founded
- 6 December 1999 26 years in operation
- Share capital
- 2.00 MNOK
- Business address
- Kjelsåsveien 161, 0884 OSLO
- Municipality
- Oslo rank 63–220 of 357 in Norway
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 31 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 31 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 52 | 74 | 45 | |
| Rank | 1,084 | 202 | 1,476 | |
| Operating margin | −0.5% | 21.9% | 8.3% | |
| Return on assets | 8.0% | 38.6% | 14.2% | |
| Equity ratio | 79.2% | 60.6% | 50.3% | |
| Current ratio | 1.47 | 1.08 | 1.00 | |
| Revenue growth | – | 43.9% | −12.7% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 1,380.1 MNOK | 1,985.8 MNOK | 1,734.1 MNOK |
| Operating profit | −6.5 MNOK | 435.4 MNOK | 144.7 MNOK |
| Profit before tax | 78.8 MNOK | 489.9 MNOK | 151.6 MNOK |
| Net profit | 62.3 MNOK | 382.4 MNOK | 118.9 MNOK |
| Financial expenses | 48.4 MNOK | 33.8 MNOK | 29.7 MNOK |
| Total assets | 1,596.1 MNOK | 1,357.3 MNOK | 1,281.3 MNOK |
| Current assets | 487.1 MNOK | 579.1 MNOK | 635.5 MNOK |
| Equity | 1,264.9 MNOK | 822.3 MNOK | 644.2 MNOK |
| Retained earnings | 62.3 MNOK | 382.4 MNOK | 204.3 MNOK |
| Total liabilities | 331.2 MNOK | 535.0 MNOK | 637.2 MNOK |
| Current liabilities | 331.2 MNOK | 535.0 MNOK | 637.2 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 31 October 2026, accounts id 5308129.
Further
Similar companies
- Framo AS index 53, rank 1,054 · compare
- Life Technologies AS index 53, rank 1,055 · compare
- Mascot Høie AS index 52, rank 1,065 · compare
- Finnfjord AS index 51, rank 1,098 · compare
- Saferoad Vik Ørsta AS index 51, rank 1,100 · compare